SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.61-0.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JamesK who wrote (51951)6/3/2022 9:39:15 PM
From: A.J. Mullen  Read Replies (1) of 52153
 
I sold half my ALNY in June of last year and wish I'd chosen one of several others). Being in revenue (not profit), it's lost less than many. It's now has 1.5 x standard weight in my portfolio. I'm unaware of BBIO's connection.

Immunic (IMUX) was holding up very well in the current environment given it is revenue-free. It dropped nearly 50% on announcing results in ulcerative colitis. I hold a small position and have not sold on the news, consoling myself that now their meagre cash need not be spread so far.

Ashley
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News